Coronavirus
WHO recommends Eli Lilly, GSK-Vir's drugs, widening COVID treatment
Baricitinib improves survival rate and reduces the need for ventilation, guidelines say
Pharmaceuticals
Caixin
China's Kangmei former chief jailed for 12 years in final verdict
Court finds drugmaker and auditors responsible for $385m loss to investors
COVID vaccines
India begins rolling out booster doses for vulnerable people
Move comes amid alarming rise in daily COVID cases
COVID vaccines
Sinovac booster insufficient against omicron, study shows
China COVID vaccine fails to produce enough antibodies: Hong Kong universities
COVID vaccines
Pharmacy of the world: China's quest to be the No. 1 drugmaker
How policy, people and cash are driving growth -- and sparking a backlash
Pharmaceuticals
Japan says Eisai-Biogen's Alzheimer drug hard to assess
Ministry needs more data after inconsistent findings, despite U.S. approval
Coronavirus
Shionogi's new COVID pill appears to ease omicron symptoms
Japanese drugmaker's treatment raises hopes of limiting hospitalizations
Datawatch
Japan falling behind in developing biopharmaceutical drugs
Trade deficit in medicines likely to top $26bn in 2021 due to weak R&D
COVID vaccines
Two Sinovac shots not enough for omicron, but 3rd shows effect
Double dose of Pfizer shows more protection than Chinese shot
COVID vaccines
Pfizer booster highly effective against omicron: study
Receiving just 2 shots offers almost no protection against COVID-19 variant
Caixin
Fosun and BioNTech to develop vaccine targeting omicron
Many drugmakers expect efficacy of existing jabs lower against new variant
Coronavirus
Japan expects to approve Merck's COVID pill in December
First oral medication expected to work on omicron variant
COVID vaccines
Moderna chief predicts existing vaccines will struggle with omicron
Stephane Bancel foresees 'material drop' in effectiveness of current jabs against new variant
COVID vaccines
Shionogi and Daiichi Sankyo join hunt for omicron vaccine
Japanese drugmakers prepare to modify shots under development
Coronavirus: Free to read
Coronavirus: Week of Nov. 21 to Nov. 27, WTO postpones ministerial conference
U.S. to bar visitors from southern Africa; WHO names new COVID variant 'omicron'
Coronavirus: Free to read
Coronavirus: Week of Nov. 14 to Nov. 20, Hong Kong authorizes Sinovac vaccine for children aged 3-17
U.S. FDA authorizes boosters for all adults; Japan cabinet approves record stimulus
Pharmaceuticals
Eisai-Biogen Alzheimer's drug draws doubt from European regulators
Vote by European Medicines Agency panel deals setback to controversial $56,000-a-year treatment
Caixin
China searches for best tool kit to contain COVID-19
Country trying to strengthen lines of defense as pandemic persists
Economy
Vietnam bags greentech and vaccine investment from U.K., France
Standard Chartered, Sanofi and AstraZeneca scramble to gain foothold
Pharmaceuticals
Japanese Nobel laureate settles with Ono Pharma over Opdivo suit
Settlement to go as donation to Kyoto University, where Tasuku Honjo is professor